Jodi Dougan

ORCID: 0009-0008-4271-1288
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Lymphoblastic Leukemia research
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Signaling Pathways in Disease
  • RNA Interference and Gene Delivery
  • Immunotherapy and Immune Responses
  • Peptidase Inhibition and Analysis
  • Immune Response and Inflammation
  • Tannin, Tannase and Anticancer Activities
  • Cancer-related molecular mechanisms research
  • Curcumin's Biomedical Applications
  • Chronic Myeloid Leukemia Treatments
  • Prostate Cancer Treatment and Research
  • T-cell and Retrovirus Studies
  • Glycosylation and Glycoproteins Research
  • Genomics, phytochemicals, and oxidative stress
  • Galectins and Cancer Biology
  • Macrophage Migration Inhibitory Factor
  • Chronic Lymphocytic Leukemia Research
  • Monoclonal and Polyclonal Antibodies Research
  • RNA modifications and cancer
  • Histone Deacetylase Inhibitors Research
  • Cancer Cells and Metastasis
  • Bone health and treatments
  • Bone and Dental Protein Studies

Emory University
2019-2024

Brookline Public Schools
2024

Clark Atlanta University
2016-2021

Center for Cancer Research
2016-2021

Emory and Henry College
2020

Children's Healthcare of Atlanta
2020

Cancer Institute (WIA)
2020

NewYork–Presbyterian Brooklyn Methodist Hospital
2012

Peroxidasin (PXDN), a human homolog of Drosophila PXDN, belongs to the family heme peroxidases and has been found promote oxidative stress in cardiovascular tissue, however, its role prostate cancer not previously elucidated. We hypothesized that PXDN promotes progression via regulation metabolic pathways. analyzed expression tissue by immunohistochemistry increased with as compared normal or cells. knockdown followed proteomic analysis revealed an increase stress, mitochondrial dysfunction...

10.3390/ijms20123046 article EN International Journal of Molecular Sciences 2019-06-21

The epithelial mesenchymal transition (EMT) promotes tumor migration and invasion by downregulating markers such as E-cadherin upregulating vimentin. Cathepsin L (Cat L) is a cysteine protease that can proteolytically activate CCAAT displacement protein/cut homeobox transcription factor (CUX1). We hypothesized nuclear Cat may promote EMT via CUX1 this could be antagonized with the L-specific inhibitor Z-FY-CHO. Mesenchymal prostate (ARCaP-M ARCaP-E overexpressing Snail) breast (MDA-MB-468,...

10.1128/mcb.00297-16 article EN Molecular and Cellular Biology 2016-12-13

Abstract Immunotherapies have revolutionized the treatment of B-cell acute lymphoblastic leukemia (B-ALL), but duration responses is still sub-optimal. We sought to identify mechanisms immune suppression in B-ALL and strategies overcome them. Plasma collected from children with measurable residual disease after induction chemotherapy showed differential cytokine expression, particularly IL-7, while single-cell RNA-sequencing revealed expression genes associated exhaustion cell subsets. also...

10.1038/s41598-022-16152-z article EN cc-by Scientific Reports 2022-07-13

Siglec-15 (Sig15) has been implicated as an immune checkpoint expressed in solid tumor-infiltrating macrophages and is being targeted clinical trials with mAbs to normalize the tumor microenvironment stimulate antitumor immunity. However, role of Sig15 hematologic malignancies remains undefined. mRNA protein expression levels were determined from publicly available databases, cell lines, primary patient samples. Human B-cell acute lymphoblastic leukemia (B-ALL) lines used identify signaling...

10.1158/2767-9764.crc-23-0056 article EN cc-by Cancer Research Communications 2023-06-24

Exploitation of the immune system has emerged as an important therapeutic strategy for acute lymphoblastic leukemia (ALL). However, mechanisms evasion during progression remain poorly understood. We sought to understand role calcineurin in ALL and observed that depletion B (CnB) cells dramatically prolongs survival immune-competent but not immune-deficient recipients. Immune-competent recipients were protected from challenge with if they first immunized CnB-deficient leukemia, suggesting...

10.1158/0008-5472.can-18-3800 article EN Cancer Research 2019-05-30

Therapies that bind with immune cells and redirect their cytotoxic activity toward diseased represent a promising versatile approach to immunotherapy applications in cancer, lupus, other diseases; traditional methods for discovering these therapies, however, are often time-intensive lack the throughput of related target-based discovery approaches. Inspired by observation cytokine, IL-12, can enhance antileukemic clinically approved T cell redirecting therapy, blinatumomab, here we describe...

10.1021/acscombsci.0c00081 article EN publisher-specific-oa ACS Combinatorial Science 2020-08-03

Abstract Prostate cancer (PCa) patients’ mortality is mainly attributed to complications caused by metastasis of the tumor cells organs critical for survival, such as bone. We hypothesized that PCa cell‐bone interactions would promote paracrine signaling. A panel cell lines were cocultured with hydroxyapatite ([HA]; inorganic component bone) different densities. Conditioned media (CM) was collected and analyzed calcium levels effect on signaling, migration, viability in vitro vivo. Our...

10.1002/mc.23019 article EN Molecular Carcinogenesis 2019-05-02

ABSTRACT Therapies that bind with immune cells and redirect their cytotoxic activity towards diseased represent a promising versatile approach to immunotherapy applications in cancer, lupus, other diseases; traditional methods for discovering these therapies, however, are often time-intensive lack the throughput of related target-based discovery approaches. Inspired by observation cytokine, IL-12, can enhance antileukemic clinically approved T cell redirecting therapy, blinatumomab, here we...

10.1101/2020.05.08.082628 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-05-10

Abstract Macrophages engulf apoptotic bodies and cellular debris as part of homeostasis, but they can also phagocytose live cells such aged red blood cells. Pharmacologic reprogramming with the SMAC mimetic LCL161 in combination T cell-derived cytokines induce macrophages to cancer mouse models. Here we extend these findings encompass a wide range monovalent bivalent compounds, demonstrating that cell phagocytosis is class effect agents. We demonstrate robust pancreatic breast by primary...

10.1101/2024.11.25.625306 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-11-28

Abstract Prostate cancer (PCa) is the most frequently diagnosed in men, second leading cause of male deaths U.S, and also presents greatest racial disparity any U.S. The incidence mortality PCa higher African-American men (AA), compared to other ethnic groups. Epithelial Mesenchymal Transition (EMT) a key event tumor migration invasion processes whereby epithelial cells lose polarity together with cell-cell contacts associated loss markers such as E-cadherin then undergo dramatic remodeling...

10.1158/1538-7755.disp15-b93 article EN Cancer Epidemiology Biomarkers & Prevention 2016-03-01

Abstract Prostate cancer is the most diagnosed in men and second leading cause of death United States. African American have highest incidence mortality rates prostate compared to any other race. Epithelial-mesenchymal transition (EMT) plays a critical role progression metastasis. Mesenchymal cells are migratory, invasive, more resistant apoptosis. Reactive Oxygen Species (ROS) has been shown promote EMT. High mobility group A (HMGA2) non-histone protein that highly expressed during...

10.1158/1538-7445.am2016-1595 article EN Cancer Research 2016-07-15

<div>Abstract<p>Exploitation of the immune system has emerged as an important therapeutic strategy for acute lymphoblastic leukemia (ALL). However, mechanisms evasion during progression remain poorly understood. We sought to understand role calcineurin in ALL and observed that depletion B (CnB) cells dramatically prolongs survival immune-competent but not immune-deficient recipients. Immune-competent recipients were protected from challenge with if they first immunized...

10.1158/0008-5472.c.6510962.v1 preprint EN 2023-03-31
Coming Soon ...